共 299 条
[1]
Sagara I(2018)Pyronaridine–artesunate or dihydroartemisinin–piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial Lancet 391 1378-1390
[2]
Beavogui AH(2020)Efficacy and safety of pyronaridine-artesunate for the treatment of uncomplicated Am J Trop Med Hyg 103 1088-1093
[3]
Zongo I(2020) and Malar J 19 374-1971
[4]
Soulama I(2014) malaria in Myanmar J Infect Dis 210 1962-8
[5]
Borghini-Fuhrer I(2015)Global estimation of anti-malarial drug effectiveness for the treatment of uncomplicated Malar J 14 27-65
[6]
Fofana B(2020) malaria 1991–2019 Malar J 19 8-765
[7]
Han KT(2020)Randomized trial of artesunate Pan Afr Med J 200 57-991
[8]
Lin K(2009)amodiaquine, atovaquone J Infect Dis 15 125-443
[9]
Han ZY(2016)proguanil, and artesunate-atovaquone-proguanil for the treatment of uncomplicated Malar J 41 753-55
[10]
Myint MK(2018) malaria in children Drug Saf 46 985-2464